Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32462 total
EROC reports its first earnings as a public company today against a backdrop that mixes genuine institutional enthusiasm with a stock that has lost ground since its July debut. The most telling story heading into this…
Churchill Capital Corp XI (CCXI) reports today with the lending market telling a notably different story from just six weeks ago — and a roster of institutional arbitrageurs watching closely. The clearest shift is in…
Maze Therapeutics reports today with a notable divergence at the heart of its setup: short sellers have been adding positions steadily, yet the lending market remains far from stressed — leaving the real tension…
Bitdeer Technologies Group heads into its August 12 earnings event carrying the wreckage of a brutal post-earnings sell-off, with short sellers firmly entrenched and options traders now the most defensively positioned…
BLTE arrives at tomorrow's earnings print on the back of its strongest monthly run in recent memory, with the stock up 19% over the past month and 13% in the last week alone to close at $177.58. The borrow market tells…
Tango Therapeutics reports today against a backdrop that could not be more divided: short sellers control nearly a third of the free float, yet analysts have been aggressively raising targets since June. Short interest…
Erasca reports tonight carrying one of the more loaded short-interest profiles in clinical-stage biotech: roughly 10.7% of the free float is sold short, a level that has been gradually unwinding — down about 1.6% over…
N-able reports Q2 results on August 13 against the most dramatic single-week sell-off the stock has seen in recent memory. The dominant story heading into this print is the price collapse itself. The stock fell nearly…
NPCE reports today with the Street broadly constructive but key questions about profitability still unanswered. Options positioning has tilted more defensive in the run-up to the print. The put/call ratio climbed to…
Analyst desks were busy on August 12, with upgrades, downgrades, and notable target price lifts across several sectors. HRL received the day's standout upgrade. Hormel Foods moved higher in consensus after analysts…
Ouster heads into its August 13 earnings report with a meaningful short position, a stock that has nearly doubled year-to-date, and analysts steadily lifting their targets — a setup that puts real pressure on the…
Immunome heads into its August 13 earnings report with a clear tension: the stock is drifting higher while nearly every insider who can sell, is selling. The insider activity is the standout signal. Over the past 90…
Taysha Gene Therapies reports this morning with short sellers sitting on a 16.5% short interest position — one of the larger bets against a clinical-stage biotech in the gene therapy space — while every analyst…
Hyliion Holdings heads into its August 12 earnings release with short sellers meaningfully positioned and the stock under fresh pressure. Short interest has climbed sharply over the past month — the most telling signal…
Aquestive Therapeutics heads into today's earnings print with options traders at their most defensive in a year, even as short sellers show early signs of pulling back. The options market is sending the loudest…
PAGS enters its Q2 earnings report today carrying a short position that has grown meaningfully — 11.4% of the free float is currently sold short, up roughly 8.5% over the past month — while the stock has shed 6.4% on…
SELLAS Life Sciences Group heads into its August 12 earnings report as one of the most heavily shorted small-cap biotechs in the market, with the lending pool telling a story of sustained bear conviction — even as…
SVRA reports August 12 results as the stock trades at $5.57 — down 8% over the past month but recovering modestly over the past week — with short sellers holding one of the largest positions in small-cap biotech. Short…
Lumentum Holdings arrives at its August 14 earnings with the options market flashing its most defensive signal of the past year — a marked shift from the bullish positioning that defined the run-up to the now-passed…
Board member Keith Meister filed a flurry of sales in ILMN this week. His total disposals exceeded $108M across five separate transactions. Shares changed hands between $198 and $203. Meister sits on Illumina's board…
